Claybrook Capital, LLC Merck & Co., Inc. Transaction History

Claybrook Capital, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$83.49 - $94.64 $2.41 Million - $2.74 Million	-28,909 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$73.51 - $82.4 $36,755 - $41,200	-500 Reduced 1.7%	28,909 $2.37 Million
Q4 2021 Jan 20, 2022	BUY	$72.28 - $90.54 $7,155 - $8,963	99 Added 0.34%	29,409 $2.25 Million
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $1.57 Million - $1.73 Million	-21,946 Reduced 42.82%	29,310 $2.2 Million
Q2 2021 Jul 26, 2021	BUY	$70.31 - $77.77 $2.23 Million - $2.47 Million	31,756 Added 162.85%	51,256 $3.99 Million
Q1 2021 Apr 30, 2021	BUY	$68.86 - $81.11 $206,580 - $243,330	3,000 Added 18.18%	19,500 $1.5 Million
Q3 2020 Oct 28, 2020	BUY	$73.18 - $82.95 $73,180 - $82,950	1,000 Added 6.45%	16,500 $1.37 Million
Q2 2020 Jul 29, 2020	BUY	$70.42 - $80.13 $845,040 - $961,560	12,000 Added 342.86%	15,500 $1.2 Million
Q1 2019 May 15, 2019	BUY	$69.58 - $79.36 $51,280 - $58,488	737 Added 26.67%	3,500 $291,000
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $279,683 - $324,568	-4,287 Reduced 60.81%	2,763 $201,000
Q3 2018 Nov 23, 2018	SELL	$57.69 - $67.84 $1.12 Million - $1.31 Million	-19,350 Reduced 73.3%	7,050 $500,000
Q1 2018 May 11, 2018	BUY	$50.96 - $59.23 $298,116 - $346,495	5,850 Added 28.47%	26,400 $1.44 Million
Q4 2017 May 08, 2018	BUY	$51.62 - $61.64 $1.06 Million - $1.27 Million	20,550	20,550 $1.16 Million

3,824

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Claybrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Claybrook Capital, LLC with notifications on news.